Malignant : how bad policy and bad evidence harm people with cancer
(Book)
Author
Status
General Shelving - 3rd Floor
RC271.C5 P73 2020
1 available
RC271.C5 P73 2020
1 available
Description
Loading Description...
Also in this Series
Checking series information...
Copies
| Location | Call Number | Status |
|---|---|---|
| General Shelving - 3rd Floor | RC271.C5 P73 2020 | On Shelf |
Subjects
LC Subjects
Antineoplastic agents -- Economic aspects -- United States.
Cancer -- Chemotherapy -- United States.
Drug development -- Economic aspects -- United States.
Medical policy -- United States.
Medical policy.
Medicine -- Research -- Economic aspects -- United States.
Patients -- Civil rights -- United States.
Cancer -- Chemotherapy -- United States.
Drug development -- Economic aspects -- United States.
Medical policy -- United States.
Medical policy.
Medicine -- Research -- Economic aspects -- United States.
Patients -- Civil rights -- United States.
OCLC Fast Subjects
Other Subjects
Anticancéreux -- Aspect économique -- États-Unis.
Antineoplastic Agents -- economics
Biomedical Research -- economics
Cancer -- Chimiothérapie -- États-Unis.
Drug Development -- economics
Health Policy
Médecine -- Recherche -- Aspect économique -- États-Unis.
Médicaments -- Développement -- Aspect économique -- États-Unis.
Neoplasms -- drug therapy
Patient Rights
Patients -- Droits -- États-Unis.
Politique sanitaire -- États-Unis.
Politique sanitaire.
United States
Antineoplastic Agents -- economics
Biomedical Research -- economics
Cancer -- Chimiothérapie -- États-Unis.
Drug Development -- economics
Health Policy
Médecine -- Recherche -- Aspect économique -- États-Unis.
Médicaments -- Développement -- Aspect économique -- États-Unis.
Neoplasms -- drug therapy
Patient Rights
Patients -- Droits -- États-Unis.
Politique sanitaire -- États-Unis.
Politique sanitaire.
United States
More Details
Format
Book
Physical Desc
ix, 289 pages : illustrations ; 24 cm
Language
English
Notes
Bibliography
Includes bibliographical references and index.
Description
"In this critical study of current cancer therapies, Dr. Prasad, an oncologist and hematologist, examines oncology practice and policy in the United States. His book is organized into four sections: (1) an overview of cancer drugs, (2) forces that distort cancer medicine and practice, (3) details about cancer research and practice, (4) recommended solutions on multiple levels (policy, practitioners, medical education, and pharmacology)"--,Provided by publisher.
Local note
SACFinal081324
Reviews from GoodReads
Loading GoodReads Reviews.
Citations
APA Citation, 7th Edition (style guide)
Prasad, V. K. (2020). Malignant: how bad policy and bad evidence harm people with cancer . Johns Hopkins University Press.
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)Prasad, Vinayak K., 1982-. 2020. Malignant: How Bad Policy and Bad Evidence Harm People With Cancer. Baltimore, Maryland: Johns Hopkins University Press.
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)Prasad, Vinayak K., 1982-. Malignant: How Bad Policy and Bad Evidence Harm People With Cancer Baltimore, Maryland: Johns Hopkins University Press, 2020.
Harvard Citation (style guide)Prasad, V. K. (2020). Malignant: how bad policy and bad evidence harm people with cancer. Baltimore, Maryland: Johns Hopkins University Press.
MLA Citation, 9th Edition (style guide)Prasad, Vinayak K. Malignant: How Bad Policy and Bad Evidence Harm People With Cancer Johns Hopkins University Press, 2020.
Note! Citations contain only title, author, edition, publisher, and year published. Citations should be used as a guideline and should be double checked for accuracy. Citation formats are based on standards as of August 2021.
Staff View
Loading Staff View.